Expert Video - Why does AML treatment failure happen after chemo and/or radiation therapy?
Dr. Barry Skikne, an expert on acute myeloid leukemia (AML) at the University of Kansas Medical Center in Kansas City, describes how AML and leukemic cells may arise after treatment with chemotherapy and/or radiation therapy. He talks about prior exposure to various toxins (chemotherapy agents, radiation treatment, petrochemical toxins) that may put a person at increased risk of developing AML. He also explains the importance of long-term monitoring and explains residual disease versus complete remission.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.
This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.
This activity is supported by educational grants from AbbVie, Acceleron, Bristol-Myers Squibb, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.